Prescriptions made by Paul Alan Stewart

Data for 2018

2,989

Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 49 providers in this state and specialty

$783K

Total Retail Price of All Prescriptions

Rank: 17 out of 49 providers in this state and specialty

642

Patients Receiving at Least One Drug in Part D

Rank: 2 out of 49 providers in this state and specialty

85%

Patients 65 Years and Older

72

Average Age of Patients

Average age of patients for providers in this state and specialty is 71

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Pulmonary Disease in Nevada and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 MONTELUKAST SODIUM50
of 310
2700 prescriptions
Less than 1% of all prescriptions
2290970 patients
15% of all patients
820 patients
13% of all patients
2 BREO ELLIPTA
(FLUTICASONE/VILANTEROL)
30
of 310
2590 prescriptions
Less than 1% of all prescriptions
2240720 patients
11% of all patients
< 11
3 PREDNISONE40
of 370
2840 prescriptions
Less than 1% of all prescriptions
24701530 patients
24% of all patients
1340 patients
21% of all patients
4 SYMBICORT
(BUDESONIDE/FORMOTEROL FUMARATE)
110
of 350
1810 prescriptions
Less than 1% of all prescriptions
580 patients
9% of all patients
< 11
5 ADVAIR DISKUS
(FLUTICASONE PROPION/SALMETEROL)
80
of 320
1520 prescriptions
Less than 1% of all prescriptions
1120460 patients
7% of all patients
350 patients
5% of all patients
6 VENTOLIN HFA
(ALBUTEROL SULFATE)
40
of 310
2080 prescriptions
Less than 1% of all prescriptions
1760830 patients
13% of all patients
670 patients
10% of all patients
7 SPIRIVA
(TIOTROPIUM BROMIDE)
60
of 290
1050 prescriptions
Less than 1% of all prescriptions
820250 patients
4% of all patients
< 11
8 ANORO ELLIPTA
(UMECLIDINIUM BRM/VILANTEROL TR)
70
of 290
1120 prescriptions
Less than 1% of all prescriptions
960400 patients
6% of all patients
< 11
9 SPIRIVA RESPIMAT
(TIOTROPIUM BROMIDE)
130
of 250
820 prescriptions
Less than 1% of all prescriptions
600270 patients
4% of all patients
< 11
10 FUROSEMIDE30
of 150
630 prescriptions
Less than 1% of all prescriptions
270 patients
4% of all patients
< 11
11 PROAIR HFA
(ALBUTEROL SULFATE)
70
of 330
1210 prescriptions
Less than 1% of all prescriptions
1100520 patients
8% of all patients
< 11
12 TRELEGY ELLIPTA
(FLUTICASONE/UMECLIDIN/VILANTER)
30
of 190
760 prescriptions
Less than 1% of all prescriptions
630290 patients
5% of all patients
< 11
13 INCRUSE ELLIPTA
(UMECLIDINIUM BROMIDE)
90
of 290
670 prescriptions
Less than 1% of all prescriptions
460130 patients
2% of all patients
< 11
14 CLARITHROMYCIN10
650 prescriptions
Less than 1% of all prescriptions
230 patients
4% of all patients
< 11A
15 OMEPRAZOLE30
of 130
540 prescriptions
Less than 1% of all prescriptions
410220 patients
3% of all patients
< 11
16 CIPROFLOXACIN HCL10
of 40
580 prescriptions
Less than 1% of all prescriptions
270 patients
4% of all patients
< 11A
17 FLUTICASONE PROPIONATE140
of 280
360 prescriptions
Less than 1% of all prescriptions
240190 patients
3% of all patients
< 11
18 METOCLOPRAMIDE HCL10
450 prescriptions
Less than 1% of all prescriptions
320240 patients
4% of all patients
< 11
19 COMBIVENT RESPIMAT
(IPRATROPIUM/ALBUTEROL SULFATE)
30
of 160
360 prescriptions
Less than 1% of all prescriptions
< 11< 11
20 POTASSIUM CHLORIDE20
of 80
310 prescriptions
Less than 1% of all prescriptions
310130 patients
2% of all patients
130 patients
2% of all patients
21 FLOVENT HFA
(FLUTICASONE PROPIONATE)
70
of 130
180 prescriptions
Less than 1% of all prescriptions
180< 11< 11
22 ADVAIR HFA
(FLUTICASONE PROPION/SALMETEROL)
40
of 80
280 prescriptions
Less than 1% of all prescriptions
< 11< 11
23 DULERA
(MOMETASONE/FORMOTEROL)
80
of 100
180 prescriptions
Less than 1% of all prescriptions
110 patients
2% of all patients
< 11
24 ARNUITY ELLIPTA
(FLUTICASONE FUROATE)
100
of 150
200 prescriptions
Less than 1% of all prescriptions
< 11< 11
25 STIOLTO RESPIMAT
(TIOTROPIUM BR/OLODATEROL HCL)
150
of 170
180 prescriptions
Less than 1% of all prescriptions
110 patients
2% of all patients
< 11
26 IPRATROPIUM-ALBUTEROL
(IPRATROPIUM/ALBUTEROL SULFATE)
40
of 70
660 prescriptions
Less than 1% of all prescriptions
< 11< 11
27 LEVOFLOXACIN10
of 170
520 prescriptions
Less than 1% of all prescriptions
400 patients
6% of all patients
< 11A
28 DALIRESP
(ROFLUMILAST)
150
of 160
140 prescriptions
Less than 1% of all prescriptions
140< 11< 11
29 RANITIDINE HCL30
of 30
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
30 AZITHROMYCIN110
of 260
640 prescriptions
Less than 1% of all prescriptions
560 patients
9% of all patients
< 11A
31 THEOPHYLLINE ANHYDROUS70
of 80
120 prescriptions
Less than 1% of all prescriptions
120< 11< 11
32 ATROVENT HFA
(IPRATROPIUM BROMIDE)
30
of 30
140 prescriptions
Less than 1% of all prescriptions
< 11< 11
33 GLASSIA
(ALPHA-1-PROTEINASE INHIBITOR)
10
120 prescriptions
Less than 1% of all prescriptions
00< 1100 patients
Less than 1% of all patients
34 MOMETASONE FUROATE10
110 prescriptions
Less than 1% of all prescriptions
110< 11< 11
35 BUDESONIDE30
of 50
200 prescriptions
Less than 1% of all prescriptions
200< 11< 11
36 FLUCONAZOLE20
of 40
200 prescriptions
Less than 1% of all prescriptions
200170 patients
3% of all patients
170 patients
3% of all patients
37 METHYLPREDNISOLONE90
of 130
160 prescriptions
Less than 1% of all prescriptions
160 patients
2% of all patients
< 11